InvestorsHub Logo
Followers 0
Posts 22925
Boards Moderated 1
Alias Born 10/28/2010

Re: stockchaser64 post# 143451

Monday, 09/15/2014 11:03:53 AM

Monday, September 15, 2014 11:03:53 AM

Post# of 158400
~ BMSN = 0.0016 -0.0001 (-5.88%)LOD..so.FarRr! frown

Bummer,, because as people buy these .0016's they then put them up on the .0017's and it ends up pushing BMSN lower then .0016!
frown

...sOOO sad! frown

RGBP = 0.128 -0.022 (-14.67%)right now and was down to .10!!!LOD..so farRr TODAY!! frown ...since BMSN owns 58% of RGBP,, as the value of RGBP goes down,, so does the value of BMSN!! frown

stockchaser64

BMSN STOCK lost any trust from investors that is why it continue to go down some have now figure out what koos plans are.THIS STOCK HAS been supported by entb dilution and now sister company time is running out.I do believe this stock will no longer trade soon.BMSN STOCK NOW become the entb for koos plan to fund regen with bmsn dilution and promises of hope which we see all the fda approval prs are the same everytime more info needed.

THESE DOCTORS that are call good doctors look like fools i am sorry this been going on and on for years and no one believe they dont know what fda rules are about approval of any drug.THIS is ridiculous to thank these smart doctors that koos said is on his team which alot of questions are being ask are they really which i have big questions too why they dont know fda rules.KOOS will run bmsn in the ground and yes try to post hope so investors will continue to fund his new toy stock regen.BUT soon before the end of the year a huge R/S/M will happen dr koos want only one big stock toy to play with and he will have it soon.beware of bmsn strong sell headed toward .0011 lows or lower

























































___________
As always,, the above Post is "Just My Opinion!" wink

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.